Hers vs Mochi Health: Wegovy vs Compounded Semaglutide Options
Hers vs Mochi Health is a comparison between a brand-name, FDA-approved Wegovy® pathway and a lower-cost, compounded-focused alternative. Early verdict: choose Hers if you want FDA-approved, brand-name Wegovy® with a personalized care team and dose check-ins; choose Mochi Health if you prioritize lower starting prices and live video doctor visits with compounded medication options.
Explore Hers plans and FDA-approved Wegovy® options
Key difference 1: Medication type and regulatory status
Hers emphasizes FDA-approved, brand-name Wegovy® and states no compounded medications are offered. The source repeats that Wegovy® is FDA-approved brand-name semaglutide and is not a compounded product. Mochi Health primarily offers compounded semaglutide and compounded tirzepatide products, and the source notes compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
See Mochi Health compounded medication options
Key difference 2: Pricing structure and starting cost
Pricing is a core contrast. Hers lists Wegovy® pill from $149/mo and injectable from $199/mo, and specifies that an active Hers Weight Loss Membership is required with a promotional first month fee then auto-renew at a listed rate. Mochi advertises compounded semaglutide starting at $99 and highlights membership-plus-medication pricing that starts from $99/month with a promotional first month option. Mochi also offers a 50% off first month code in the source.
Compare Hers pricing and membership terms
Key difference 3: Clinical visit model and ongoing care
Hers promotes a personalized care team with ongoing dose check-ins as part of its model. Mochi Health distinguishes itself by offering live video visits with a doctor bookable in about 5 minutes, noting this synchronous model differs from the asynchronous text reviews many competitors use. Mochi also advertises 24/7 support and ongoing appointment availability throughout the program.
Other practical differences: Availability and membership notes
Hers states medications are not available without an active membership and that treatment is available only when a licensed clinician determines it is medically appropriate; it also says not available in all 50 states. Mochi states reliable GLP-1 prescription access in all 50 states and that terms vary by state. Both sources include the regulatory note that compounded medications are not FDA-approved and not reviewed by FDA for safety, effectiveness or quality.
| Criteria | Hers | Mochi Health |
|---|---|---|
| Starting price | Wegovy® pill from $149/mo; injectable from $199/mo | Compounded semaglutide starting $99; membership-plus-medication structure |
| Medication type | FDA-approved Wegovy®; name brand semaglutide; no compounded medications | Compounded semaglutide and tirzepatide options; compounded focus |
| Visit model | Personalized care team with ongoing dose check-ins (as stated) | Live video visits with a doctor bookable in about 5 minutes; 24/7 support |
| Membership | Active Hers Weight Loss Membership required; membership and medication billed separately | Membership-plus-medication pricing; promotional first month offers, then standard rates |
| State availability | Not available in all 50 states (source states limited availability) | Claims reliable prescription access in all 50 states |
| Regulatory note | Emphasizes brand-name FDA-approved Wegovy®; notes compounded meds are not FDA-approved | Notes compounded meds are not FDA-approved and are not reviewed by FDA for safety or effectiveness |
What each provider highlights as pros and cons
Hers: Pros listed in the source are FDA-approved brand-name Wegovy®, not a compounded product, personalized care team with ongoing dose check-ins, and no insurance required. A con listed is a higher starting price than most compounded competitors and no compounded or generic alternative offered. Mochi Health: Pros listed include live video visits with a doctor in about 5 minutes, 50% off first month with a code, reliable GLP-1 prescription access in all 50 states, and membership-plus-medication pricing starting as low as $99/month. Mochi’s cons include variable total cost because pricing is membership plus medication and a compounded medication focus rather than branded options.
Final comparison take and how to choose
Hers vs Mochi Health hinges on FDA-approved brand-name access, price transparency, and visit style. Hers provides FDA-approved Wegovy® from $149/mo and emphasizes a personalized care team and dose check-ins with no compounded medications. Mochi Health offers compounded semaglutide starting at $99, live video doctor visits bookable in about 5 minutes, 24/7 support, and a membership-plus-medication pricing model with promotional first month pricing.
Choose Hers if you want brand-name, FDA-approved Wegovy® with a stated personalized care team and ongoing dose check-ins and accept the membership requirements and higher starting price.
Choose Mochi Health if you prefer lower starting membership-plus-medication pricing, compounded semaglutide or tirzepatide options, and live video visits with a doctor available in about 5 minutes.